Cognito Therapeutics
Cambridge, Mass.
Founded: 2016
Cognito Therapeutics is an early-stage medical device company that is focusing on the treatment of neurodegenerative diseases.
Currently, the company develops techniques that are used to induce brainwave oscillations to treat Alzheimer’s disease symptoms.
Cognito Therapeutics is in the early stages of research and development and plans to start using the techniques that it used in mouse models in humans.
–Danielle Kirsh, Assistant Editor